跳至主要内容
临床试验/NCT02011815
NCT02011815已完成不适用

A Prospective Study of Exploring Possible Biological Linkage Between Circadian Disruption and Cancer Progression

Seoul National University Hospital1 个研究点 分布在 1 个国家目标入组 236 人开始时间: 2013年11月10日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
236
试验地点
1
主要终点
Progression-free survival

研究概览

简要总结

The purpose of this study is to explore the possible association between the circadian disruption and cancer progression.

详细描述

The biological markers that are assumed to bridge this association are measured and analyzed.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Age: 18-70
  • Breast cancer patients who are getting chemotherapy for the first time in life
  • Patients are either having stage 4 cancer or starting neoadjuvant chemotherapy.
  • Patient have signed on the informed consent, and well understood the objective and procedure of this study

排除标准

  • Patients already have received chemotherapy
  • Patient had another cancer (except thyroid cancer) within 5 years
  • Patient with severe medical condition
  • Patient had taken psychiatric medication more than 1 month in life
  • Patient worked the night shift for more than 1 month in 6 months

结局指标

主要结局

Progression-free survival

时间窗: 3 years (and more) after recruitment

The data progression-free survival will be done by reviewing patients' medical record.

次要结局

  • Objective sleep cycle measures(Baseline, after 1 month, after 6 month, after 12 month)
  • Sleep quality measures(Baseline, after 1 month, after 6 month, after 12 month)
  • Distress related measure(Baseline, after 1 month, after 6 month, after 12 month)
  • Posttraumatic Stress-related symptom measure(Baseline, after 1 month, after 6 month, after 12 month)
  • Genetic polymorphism(Baseline)
  • Physiological measures(Baseline, after 1 month, after 6 month, after 12 month)
  • Cortisol level(Baseline)
  • Inflammatory markers(Baseline)
  • Overall survival(3 years (and more) after recruitment)
  • Quality of Life measure(Baseline, after 1 month, after 6 month, after 12 month)
  • Cancer related Fatigue(Baseline, after 1 month, after 6 month, after 12 month)
  • Menopausal symptom measure(Baseline, after 1 month, after 6 month, after 12 month)
  • Epigenetic Change(Baseline)
  • Circadian disruption(Baseline, after 1 month, after 6 month, after 12 month)
  • Personality measure(Baseline)
  • Melatonin(Baseline)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验